Home › Funds › Kohlberg Kravis Roberts & Co. L.P. › BTSG

Kohlberg Kravis Roberts & Co. L.P. position in BTSG

BRIGHTSPRING HEALTH SVCS INC · Health Care

Kohlberg Kravis Roberts & Co. L.P. reported holding 26,829,880 shares of BTSG (BRIGHTSPRING HEALTH SVCS INC) in its Q3 2026 13F filing — a position valued at US$1.52B, representing 35.77% of its reported portfolio and ranking #1 among its reported holdings. Kohlberg Kravis Roberts & Co. L.P. has disclosed BTSG holdings in 11 of the last 11 reported quarters, going back to Q1 2024.

Latest position (Q3 2026)26.83M sh
Reported value held$1.52B
Portfolio Weight35.77%
First reportedQ1 2024
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Kohlberg Kravis Roberts & Co. L.P.'s BTSG position evolved

Kohlberg Kravis Roberts & Co. L.P. first disclosed a stake in BTSG in Q1 2024 at 81,339,986 shares (US$884.2M). The position peaked in Q4 2025 at 61,942,032 shares, worth US$2.32B. Across 11 filings, Kohlberg Kravis Roberts & Co. L.P. increased the stake 1 time(s), trimmed it 4 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 26,829,880 shares valued at US$1.52B. Notable position changes include a 32% trim in Q1 2026 (shares rose 64% over the following quarter), a 36% trim in Q2 2026 (shares fell 19% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 81.34M $884.17M New
Q2 2024 81.34M $924.02M Hold
Q3 2024 92.96M $1.36B Add
Q4 2024 92.96M $1.58B Hold
Q1 2025 92.96M $1.68B Hold
Q2 2025 77.10M $1.82B Reduce
Q3 2025 77.10M $2.28B Hold
Q4 2025 61.94M $2.32B Reduce
Q1 2026 41.82M $1.78B Reduce
Q2 2026 26.83M $1.87B Reduce
Q3 2026 26.83M $1.52B Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BTSG and 13F data

BTSG (BRIGHTSPRING HEALTH SVCS INC) is a Health Care company. 68 other funds we track also report a position in BTSG — the largest reported positions include FULLER & THALER ASSET MANAGEMENT, INC. (US$234.4M), Marshall Wace (US$183.8M), Farallon Capital Management (US$120.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BTSG

All BTSG fund holders →

FAQ

How long has Kohlberg Kravis Roberts & Co. L.P. held BTSG?

Kohlberg Kravis Roberts & Co. L.P. has disclosed BTSG holdings in 11 of the last 11 reported quarters, going back to Q1 2024.

What is Kohlberg Kravis Roberts & Co. L.P.'s current position in BTSG?

As of Q3 2026, Kohlberg Kravis Roberts & Co. L.P. holds 26.83M shares of BTSG (BRIGHTSPRING HEALTH SVCS INC), valued at $1.52B, representing 35.77% of its reported portfolio and ranking #1.

Has Kohlberg Kravis Roberts & Co. L.P. been buying or selling BTSG?

In the latest 13F filing (Q3 2026), Kohlberg Kravis Roberts & Co. L.P. held unchanged its position in BTSG. The position peaked in Q4 2025 at 61.94M shares.

Which other funds hold BTSG?

Other major institutional holders of BTSG include FULLER & THALER ASSET MANAGEMENT, INC., Marshall Wace, Farallon Capital Management, among 68 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.